EVAX News and Press, Evaxion Biotech A/S From 02/20/24

COPENHAGEN, Denmark, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces the successful completion of the initial phases of its vaccine coll...

2024-02-12 10:00:07 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...

COPENHAGEN, Denmark, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that on February 05, 2024, it rec...

COPENHAGEN, Denmark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing on February 5, 2024 o...

2024-02-01 09:31:41 ET More on Evaxion Biotech ADS Evaxion stock rallies 120% on AI-based cancer vaccine program Evaxion announces plan to implement ADS ratio change Seeking Alpha’s Quant Rating on Evaxion Biotech ADS Historical earnings data for Evaxi...

COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the pricing of a public offering ...

2024-01-31 11:23:12 ET More on Mid-day movers & stocks. 2seventy bio: An Overload Of Troubles At This Small Pharma Ashford Hospitality Trust Preferred: Check-In To This Speculative 17.6% Yielder 2seventy bio, Inc. (TSVT) Q3 2023 Earnings Call Transcript 2...

2024-01-31 10:00:03 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-01-26 09:19:36 ET Losers: TC BioPharm ( TCBP ) -21% . Mobilicom Limited ( MOB ) -21% announces $2.95 Million registered direct offering . LAVA Therapeutics ( LVTX ) -14% . Evaxion Biotech ( EVAX ) -13% . Nxu ( NXU ) -13% ...

2024-01-24 12:48:28 ET More on Mid-day movers $ stocks. Peraso Inc. (PRSO) Q3 2023 Earnings Call Transcript Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript Sight Sciences says Q4 total revenue i...